FDA
approval
· 2013-03-09
FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
Summary
The FDA approved a supplemental application for Novo Nordisk's NOVOLIN 70/30, a human insulin product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NOVOLIN 70/30 (HUMAN INSULIN)